Skip to main content
Signal8
THOMAS PAUL profile photo

Paul Thomas

CIK: 0001166776

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)2 (25.0%)

Derivative conversions

Awards (A)5 (62.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Axogen, Inc. logo
AXGN

Axogen, Inc.

Director
TELA Bio, Inc. logo
TELA

TELA Bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Axogen, Inc. logo
    AXGN

    Axogen, Inc.

    Jun 24, 2026
    Award(A)

    Restricted Stock Units

    Direct
    5.6K shares-
  • Axogen, Inc. logo
    AXGN

    Axogen, Inc.

    Jun 19, 2026
    Exercise(M)
    Direct
    18.9K shares-
  • TELA Bio, Inc. logo
    TELA

    TELA Bio, Inc.

    Jun 9, 2026
    Award(A)
    Direct
    11.7K shares-
  • TELA Bio, Inc. logo
    TELA

    TELA Bio, Inc.

    Jun 9, 2026
    Award(A)
    Direct
    11.9K shares-
  • Axogen, Inc. logo
    AXGN

    Axogen, Inc.

    Dec 9, 2025
    Sale(S)
    Direct
    21.4K shares at avg. $29.61$634K
  • Axogen, Inc. logo
    AXGN

    Axogen, Inc.

    Jun 19, 2025
    Award(A)

    Restricted Stock Units

    Direct
    18.9K shares-
  • Axogen, Inc. logo
    AXGN

    Axogen, Inc.

    Sep 16, 2024
    Award(A)
    Direct
    2.9K shares-
  • Axogen, Inc. logo
    AXGN

    Axogen, Inc.

    Sep 1, 2024
    Exercise(M)
    Direct
    11.9K shares-

1-8 of 8

About THOMAS PAUL

THOMAS PAUL (SEC CIK 0001166776) files insider reports with the SEC as Director of Axogen, Inc. (AXGN) and Director of TELA Bio, Inc. (TELA).

Signal8 holds 8 ownership filings by THOMAS PAUL (1 Form 3, 7 Form 4), filed between Sep 4, 2024 and Jun 26, 2026. Those filings report 8 transactions, from Sep 1, 2024 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on THOMAS PAUL's filings is in MALVERN, PA.

Recent filings by THOMAS PAUL

  • Jun 24, 2026: Grant or award of AXGN derivative securities (Form 4, code A).
  • Jun 19, 2026: Option exercise of AXGN shares (Form 4, code M).
  • Jun 9, 2026: Grants or awards of TELA shares (2 lines, Form 4, code A).
  • Dec 9, 2025: Open-market sale of AXGN shares (Form 4, code S).
  • Jun 19, 2025: Grant or award of AXGN derivative securities (Form 4, code A).

Other insiders filing for Axogen, Inc. (AXGN)

How to read Form 4 transaction codes